Related Experiment Video
Updated: Jul 24, 2026

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
pp60(c-src) modulates microvascular endothelial phenotype and in vitro angiogenesis
M Marx1, S L Warren, J A Madri
1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Experimental and Molecular Pathology
|June 22, 2001
Summary
The c-src tyrosine kinase regulates endothelial cell behavior. Its activity inhibits platelet-derived growth factor (PDGF) signaling, affecting cell shape, size, and in vitro angiogenesis.
Area of Science:
- Cell Biology
- Molecular Biology
- Angiogenesis Research
Background:
- The c-src tyrosine kinase is known to associate with the platelet-derived growth factor (PDGF) receptor.
- The precise role of c-src kinase activity in endothelial cell responses to PDGF requires further elucidation.
Purpose of the Study:
- To investigate the regulatory effects of c-src tyrosine kinase on microvascular endothelial cells.
- To determine the impact of c-src overexpression and kinase activity on PDGF signaling and in vitro angiogenesis.
Main Methods:
- Overexpression of wild-type c-src, kinase-negative c-src mutant, and v-src in microvascular endothelial cells.
- Analysis of cell morphology in 2D culture and in vitro angiogenesis in 3D culture.
- Assessment of PDGF-mediated mitogenic effects and tube formation.
Main Results:
- c-src kinase activity was found to inhibit PDGF-induced mitogenic signals.
- Overexpression of c-src proteins altered endothelial cell morphology (shape and size) in 2D culture.
- In 3D culture, c-src overexpression increased tube diameter and reduced branching during angiogenesis.
- Kinase-negative c-src mutants led to abortive tube formation with disconnected multicellular fragments.
Conclusions:
- The c-src tyrosine kinase plays a critical regulatory role in endothelial cell proliferation, size, and cytoskeletal organization.
- c-src kinase activity is essential for the proper formation of a differentiated multicellular network during in vitro angiogenesis.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

